[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Krystal Biotech Inc (KRYS)

Krystal Biotech Inc (KRYS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Krystal Biotech Inc 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203 USA

www.krystalbio.com Employees: 295 P: 412-586-5830

Sector:

Medical

Description:

Krystal Biotech, Inc. is a gene therapy company. It engaged in developing and commercializing novel treatments for patients suffering from dermatological diseases. Krystal Biotech, Inc. is based in Pittsburgh, United States.

Key Statistics

Overview:

Market Capitalization, $K 8,026,020
Enterprise Value, $K 7,529,720
Shares Outstanding, K 29,436
Float, K 25,580
% Float 86.90%
Short Interest, K 3,137
Short Float 10.66%
Days to Cover 10.01
Short Volume Ratio 0.82
% of Insider Shareholders 13.10%
% of Institutional Shareholders 86.29%

Financials:

Annual Sales, $ 389,130 K
Annual Net Income, $ 204,830 K
Last Quarter Sales, $ 107,110 K
Last Quarter Net Income, $ 51,400 K
EBIT, $ 161,300 K
EBITDA, $ 167,850 K

Growth:

1-Year Return 63.47%
3-Year Return 224.60%
5-Year Return 243.23%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 500.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 1.70 on 02/17/26
Next Earnings Date 05/05/26 [BMO]
Earnings Per Share ttm 6.85
EPS Growth vs. Prev Qtr -36.09%
EPS Growth vs. Prev Year 11.84%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

KRYS Ratios

Ratio
Price/Earnings ttm 40.37
Price/Earnings forward 35.61
Price/Earnings to Growth N/A
Return-on-Equity % 18.69%
Return-on-Assets % 17.12%
Profit Margin % 52.64%
Debt/Equity 0.00
Price/Sales 20.92
Price/Cash Flow 37.93
Price/Book 6.57
Book Value/Share 42.05
Interest Coverage 2.29
60-Month Beta 0.54
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.